It sounds like you mean Brineura. Here’s a clear overview:
What is Brineura?
Brineura® (cerliponase alfa) is a prescription medicine used to treat late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2 disease)—a rare, inherited neurodegenerative disorder that affects children.
How it works
It’s a replacement enzyme therapy (a recombinant enzyme). It’s designed to help break down specific lipofuscin material in the brain.
How it’s given
- Given as an infusion directly into the brain through a surgically implanted device (an intraventricular infusion).
- It’s typically administered by healthcare professionals in a specialized setting.
- Treatment is usually done on an ongoing schedule (commonly every two weeks, depending on the protocol).
Common side effects / risks
The most notable concerns include:
- Infusion-related reactions (can include fever, vomiting, reactions around the time of infusion)
- Device-related issues related to the implanted delivery system
- Allergic-type reactions can occur
Your clinical team monitors closely during and after infusions.
Important notes
Brineura is generally used for specific patients with confirmed CLN2 disease. It’s not a general treatment for all forms of neuronal ceroid lipofuscinosis.
If you tell me what you need—e.g., uses, dosing schedule, side effects, insurance/prior authorization, or how it compares to other therapies—I can tailor the answer. Also, is this for you/patient care, or general information?